Bioventus Focused on Integrating Recent Acquisitions

By Mike Evers

Bioventus Focused on Integrating Recent Acquisitions
The company grew over +28% in 2021, driven in part by synergies from recently acquired Bioness and Misonix.

Member-Only Content

SUBSCRIBE Login

Product Labels: Synthetic Bone Graft, Viscosupplement

Tags: Revenue Report, M&A